IOL CHEMICALS & PHARM. | ANUH PHARMA | IOL CHEMICALS & PHARM./ ANUH PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 23.2 | 58.8% | View Chart |
P/BV | x | 1.6 | 5.2 | 29.7% | View Chart |
Dividend Yield | % | 1.0 | 0.8 | 126.1% |
IOL CHEMICALS & PHARM. ANUH PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ANUH PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ ANUH PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 110 | 488.4% | |
Low | Rs | 272 | 77 | 353.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 105.3 | 358.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 7.2 | 328.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 9.2 | 344.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.00 | 200.0% | |
Avg Dividend yield | % | 1.0 | 2.1 | 46.2% | |
Book value per share (Unadj.) | Rs | 256.8 | 48.1 | 533.5% | |
Shares outstanding (eoy) | m | 58.71 | 50.11 | 117.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.9 | 120.6% | |
Avg P/E ratio | x | 17.1 | 12.9 | 131.8% | |
P/CF ratio (eoy) | x | 12.8 | 10.2 | 125.5% | |
Price / Book Value ratio | x | 1.6 | 1.9 | 81.1% | |
Dividend payout | % | 16.9 | 27.7 | 60.9% | |
Avg Mkt Cap | Rs m | 23,743 | 4,683 | 507.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 172 | 980.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5,275 | 420.3% | |
Other income | Rs m | 256 | 61 | 418.8% | |
Total revenues | Rs m | 22,427 | 5,336 | 420.3% | |
Gross profit | Rs m | 2,257 | 518 | 435.6% | |
Depreciation | Rs m | 462 | 97 | 475.9% | |
Interest | Rs m | 165 | 7 | 2,207.8% | |
Profit before tax | Rs m | 1,887 | 475 | 397.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 113 | 438.5% | |
Profit after tax | Rs m | 1,391 | 362 | 384.6% | |
Gross profit margin | % | 10.2 | 9.8 | 103.6% | |
Effective tax rate | % | 26.2 | 23.8 | 110.3% | |
Net profit margin | % | 6.3 | 6.9 | 91.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 3,076 | 314.2% | |
Current liabilities | Rs m | 5,025 | 1,613 | 311.5% | |
Net working cap to sales | % | 20.9 | 27.7 | 75.5% | |
Current ratio | x | 1.9 | 1.9 | 100.9% | |
Inventory Days | Days | 43 | 66 | 65.9% | |
Debtors Days | Days | 8 | 1,185 | 0.7% | |
Net fixed assets | Rs m | 11,017 | 966 | 1,140.5% | |
Share capital | Rs m | 587 | 251 | 234.3% | |
"Free" reserves | Rs m | 14,490 | 2,162 | 670.3% | |
Net worth | Rs m | 15,077 | 2,412 | 625.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 4,042 | 511.7% | |
Interest coverage | x | 12.5 | 64.6 | 19.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.3 | 82.1% | |
Return on assets | % | 7.5 | 9.1 | 82.4% | |
Return on equity | % | 9.2 | 15.0 | 61.5% | |
Return on capital | % | 13.6 | 20.0 | 68.1% | |
Exports to sales | % | 26.7 | 52.5 | 50.9% | |
Imports to sales | % | 0 | 53.2 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 2,770 | 214.1% | |
Imports (cif) | Rs m | NA | 2,808 | 0.0% | |
Fx inflow | Rs m | 5,930 | 2,770 | 214.1% | |
Fx outflow | Rs m | 6,052 | 2,808 | 215.6% | |
Net fx | Rs m | -122 | -38 | 320.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 539 | 226.8% | |
From Investments | Rs m | -1,200 | -435 | 276.0% | |
From Financial Activity | Rs m | -41 | -123 | 33.4% | |
Net Cashflow | Rs m | -18 | -19 | 98.4% |
Indian Promoters | % | 48.2 | 69.9 | 68.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 1,214.3% | |
FIIs | % | 1.4 | 0.0 | 4,666.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 30.1 | 172.2% | |
Shareholders | 130,003 | 22,237 | 584.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ANUH PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | 6.59% | 0.97% |
1-Month | 5.64% | 2.86% | 2.08% |
1-Year | -1.14% | 189.06% | 55.37% |
3-Year CAGR | -12.91% | 23.37% | 15.04% |
5-Year CAGR | 16.34% | 30.73% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ANUH PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ANUH PHARMA the stake stands at 69.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ANUH PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ANUH PHARMA paid Rs 2.0, and its dividend payout ratio stood at 27.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ANUH PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.